Persistent Elite Controllers As the Key Model to Identify Permanent HIV Remission

Overview

Journal Curr Opin HIV AIDS

Specialty Infectious Diseases

Date 2025 Jan 8

PMID 39773856

Authors

Carmen Gasca-Capote

Ezequiel Ruiz-Mateos

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: To summarize the heterogeneity in the elite controllers population with the aim to identify a compatible profile with a persistent HIV remission, making distinction between persistent elite controllers, people with HIV (PWHIV) who permanently maintain virological control in the absence of antiretroviral treatment (ART), and transient elite controllers, PWHIV who eventually lose virological control. For this purpose, it is important to consider the mechanisms and biomarkers that have previously been associated with the maintenance and loss of the natural virological control.

Recent Findings: Transient elite controllers, before losing virological control, exhibit a distinct metabolomic, proteomic, microRNAs (miRNA), immunological and virological profile compared to persistent elite controllers. In addition to a reduced and less polyfunctional HIV-specific T-cell response, transient elite controllers show a greater proportion of intact proviruses integrated into genic regions. In contrast, persistent elite controllers display a privileged HIV-1 reservoir profile with absence of detected intact proviruses or low proportion of clonal intact proviruses preferentially integrated into genomic features associated with HIV-1 transcriptional repression.

Summary: According to previous studies, the comprehensive characterization of persistent elite controllers might be crucial to identify other PWHIV with this distinct profile as spontaneously cured.

References

Pollack R, Jones R, Pertea M, Bruner K, Martin A, Thomas A . Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host Microbe. 2017; 21(4):494-506.e4. PMC: 5433942. DOI: 10.1016/j.chom.2017.03.008. View

Migueles S, Osborne C, Royce C, Compton A, Joshi R, Weeks K . Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity. 2008; 29(6):1009-21. PMC: 2622434. DOI: 10.1016/j.immuni.2008.10.010. View

Crowell T, Ganesan A, Berry S, Deiss R, Agan B, Okulicz J . Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study. J Int AIDS Soc. 2016; 19(1):20524. PMC: 4783305. DOI: 10.7448/IAS.19.1.20524. View

Li J, Segal F, Bosch R, Lalama C, Roberts-Toler C, Delagreverie H . Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers. Clin Infect Dis. 2019; 70(8):1636-1642. PMC: 7146008. DOI: 10.1093/cid/ciz442. View

Jensen B, Knops E, Cords L, Lubke N, Salgado M, Busman-Sahay K . In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation. Nat Med. 2023; 29(3):583-587. PMC: 10033413. DOI: 10.1038/s41591-023-02213-x. View

Tarancon-Diez L, Rodriguez-Gallego E, Rull A, Peraire J, Vilades C, Portilla I . Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection. EBioMedicine. 2019; 42:86-96. PMC: 6491381. DOI: 10.1016/j.ebiom.2019.03.004. View

Naranbhai V, Carrington M . Host genetic variation and HIV disease: from mapping to mechanism. Immunogenetics. 2017; 69(8-9):489-498. PMC: 5537324. DOI: 10.1007/s00251-017-1000-z. View

Jiang C, Lian X, Gao C, Sun X, Einkauf K, Chevalier J . Distinct viral reservoirs in individuals with spontaneous control of HIV-1. Nature. 2020; 585(7824):261-267. PMC: 7837306. DOI: 10.1038/s41586-020-2651-8. View

Jarrin I, Rava M, Del Romero Raposo J, Rivero A, Romero Guerrero J, de Lagarde M . Life expectancy of people with HIV on antiretroviral therapy in Spain. AIDS. 2023; 38(3):387-395. DOI: 10.1097/QAD.0000000000003772. View

10.

Gaiha G, McKim K, Woods M, Pertel T, Rohrbach J, Barteneva N . Dysfunctional HIV-specific CD8+ T cell proliferation is associated with increased caspase-8 activity and mediated by necroptosis. Immunity. 2014; 41(6):1001-12. PMC: 4312487. DOI: 10.1016/j.immuni.2014.12.011. View

11.

Casado C, Galvez C, Pernas M, Tarancon-Diez L, Rodriguez C, Sanchez-Merino V . Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure. Sci Rep. 2020; 10(1):1902. PMC: 7002478. DOI: 10.1038/s41598-020-58696-y. View

12.

Bendenoun M, Samri A, Avettand-Fenoel V, Cardinaud S, Descours B, Carcelain G . What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM. EBioMedicine. 2017; 27:51-60. PMC: 5828297. DOI: 10.1016/j.ebiom.2017.12.003. View

13.

Mendoza D, Johnson S, Peterson B, Natarajan V, Salgado M, Dewar R . Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood. 2012; 119(20):4645-55. PMC: 3367872. DOI: 10.1182/blood-2011-10-381996. View

14.

Migueles S, Connors M . Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. JAMA. 2010; 304(2):194-201. DOI: 10.1001/jama.2010.925. View

15.

Allers K, Hutter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E . Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. Blood. 2010; 117(10):2791-9. DOI: 10.1182/blood-2010-09-309591. View

16.

Pernas M, Tarancon-Diez L, Rodriguez-Gallego E, Gomez J, G Prado J, Casado C . Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection. J Virol. 2017; 92(5). PMC: 5809746. DOI: 10.1128/JVI.01805-17. View

17.

Viard M, OhUigin C, Yuki Y, Bashirova A, Collins D, Urbach J . Impact of HLA class I functional divergence on HIV control. Science. 2024; 383(6680):319-325. PMC: 11395297. DOI: 10.1126/science.adk0777. View

18.

St-Pierre C, Manya H, Ouellet M, Clark G, Endo T, Tremblay M . Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4. J Virol. 2011; 85(22):11742-51. PMC: 3209312. DOI: 10.1128/JVI.05351-11. View

19.

Pereyra F, Addo M, Kaufmann D, Liu Y, Miura T, Rathod A . Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis. 2008; 197(4):563-71. DOI: 10.1086/526786. View

20.

Miura T, Brockman M, Schneidewind A, Lobritz M, Pereyra F, Rathod A . HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J Virol. 2009; 83(6):2743-55. PMC: 2648254. DOI: 10.1128/JVI.02265-08. View